These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 34532773)

  • 61. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
    Archer DB; Bricker JT; Chu WT; Burciu RG; McCracken JL; Lai S; Coombes SA; Fang R; Barmpoutis A; Corcos DM; Kurani AS; Mitchell T; Black ML; Herschel E; Simuni T; Parrish TB; Comella C; Xie T; Seppi K; Bohnen NI; Müller ML; Albin RL; Krismer F; Du G; Lewis MM; Huang X; Li H; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Lancet Digit Health; 2019 Sep; 1(5):e222-e231. PubMed ID: 33323270
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy.
    Ye R; Hezemans FH; O'Callaghan C; Tsvetanov KA; Rua C; Jones PS; Holland N; Malpetti M; Murley AG; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe JB
    J Neurosci; 2023 Oct; 43(42):7028-7040. PubMed ID: 37669861
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical Phenotypes of Progressive Supranuclear Palsy-The Differences in Interleukin Patterns.
    Madetko-Alster N; Otto-Ślusarczyk D; Wiercińska-Drapało A; Koziorowski D; Szlufik S; Samborska-Ćwik J; Struga M; Friedman A; Alster P
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894815
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study.
    Avenali M; Tassorelli C; De Icco R; Perrotta A; Serrao M; Fresia M; Pacchetti C; Sandrini G
    Clin Neurophysiol; 2017 Oct; 128(10):1978-1984. PubMed ID: 28829981
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
    Seckin ZI; Duffy JR; Strand EA; Clark HM; Utianski RL; Machulda MM; Botha H; Ali F; Thu Pham NT; Lowe VJ; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2020 Dec; 81():34-40. PubMed ID: 33045651
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prevalence of progressive supranuclear palsy in Yonago: change throughout a decade.
    Takigawa H; Kitayama M; Wada-Isoe K; Kowa H; Nakashima K
    Brain Behav; 2016 Dec; 6(12):e00557. PubMed ID: 28031995
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
    Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
    J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Utilizing speech analysis to differentiate progressive supranuclear palsy from Parkinson's disease.
    Kang K; Nunes AS; Sharma M; Hall AJ; Mishra RK; Casado J; Cole R; Derhammer M; Barchard G; Najafi B; Vaziri A; Wills AM; Pantelyat A
    Parkinsonism Relat Disord; 2023 Oct; 115():105835. PubMed ID: 37678101
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Finger tapping analysis in patients with Parkinson's disease and atypical parkinsonism.
    Djurić-Jovičić M; Petrović I; Ječmenica-Lukić M; Radovanović S; Dragašević-Mišković N; Belić M; Miler-Jerković V; Popović MB; Kostić VS
    J Clin Neurosci; 2016 Aug; 30():49-55. PubMed ID: 27343040
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
    Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
    Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Progressive supranuclear palsy, a case report.
    Ortiz A; Troya F; de Vera J; Vázquez E
    Arch Soc Esp Oftalmol (Engl Ed); 2024 Jul; 99(7):304-308. PubMed ID: 38768849
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy.
    Ma J; Zhang G; Zhao Z; Chan P; Ye Z
    Brain Behav; 2024 Jul; 14(7):e3606. PubMed ID: 38945805
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.
    Lopez G; Bayulkem K; Hallett M
    Acta Neurol Scand; 2016 Oct; 134(4):242-9. PubMed ID: 27070344
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Real-life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1-year follow-up data report.
    Metta V; Chaudhuri KR; Leta V; Mridula KR; Koduri C; Deepak S; Kalpala R; Reddy N; Chung-Faye G; Borgohain R
    Brain Behav; 2022 Sep; 12(9):e2547. PubMed ID: 35943202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
    Caparros-Lefebvre D; Sergeant N; Lees A; Camuzat A; Daniel S; Lannuzel A; Brice A; Tolosa E; Delacourte A; Duyckaerts C
    Brain; 2002 Apr; 125(Pt 4):801-11. PubMed ID: 11912113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.